Streetbeat News

Products Services

EWJ

LLY

Eli Lilly's obesity drug is expected to receive approval in Japan next year, according to the company's CEO. This development could expand Eli Lilly's market presence and revenue potential in the obesity treatment sector.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 2:30 pm

NFLX

TKO

Netflix is launching a live weekly talk show with comedian John Mulaney in 2025, as part of its strategy to expand live content and attract new subscribers. This move aligns with Netflix's broader push into live sports and entertainment content.

Portfolio Pulse from Chris Katje

October 11, 2024 | 2:24 pm

TSLA

Tesla shares are experiencing a decline after the unveiling of its Cybercab, as investors evaluate a potential release timeline in 2026 or 2027.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 2:19 pm

DJT

Trump Media & Technology Group Corp. (NASDAQ:DJT) shares have surged nearly 50% this week, driven by political developments and the launch of its Truth+ TV streaming app for Android. The stock's movement is more influenced by news surrounding Trump than company fundamentals.

Portfolio Pulse from Erica Kollmann

October 11, 2024 | 2:13 pm

PACB

Pacific Biosciences shares rose following a new research collaboration with the National Cancer Center of Singapore, utilizing its sequencing technologies.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 2:12 pm

CAPR

Capricor Therapeutics shares rose following the announcement of long-term data from its HOPE-2 OLE study for Duchenne muscular dystrophy, presented at the 2024 World Muscle Society Congress.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 2:07 pm

BLK

JPM

MRNA

TSLA

WFC

Tesla's stock is experiencing volatility following the unveiling of its self-driving Cybercab, with concerns over production timelines. JPMorgan Chase reports a significant increase in investment banking revenue, while Wells Fargo faces lower profits. BlackRock beats earnings projections, and Cathie Wood's Ark Invest sells Moderna stock.

Portfolio Pulse from Akanksha Bakshi

October 11, 2024 | 2:06 pm

NVDA

The article discusses the recent options trading activity for NVIDIA (NASDAQ:NVDA), highlighting a bearish sentiment among large investors. Despite a mix of bullish and bearish trades, the overall sentiment leans bearish with significant call and put options activity. NVIDIA's stock is currently priced at $134.86, with RSI indicators suggesting it may be overbought. The next earnings report is expected in 39 days.

Portfolio Pulse from Benzinga Insights

October 11, 2024 | 1:47 pm

BTTR

Better Choice shares rose as the company announced its expansion into veterinary medicine in 2025, following the acquisition of SRx Health.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 1:23 pm

CAPR

Capricor Therapeutics presented long-term data from the HOPE-2 OLE study at the 2024 World Muscle Society Congress, showing sustained efficacy and safety of Deramiocel in treating Duchenne Muscular Dystrophy. The company plans to submit a Biologics License Application by the end of 2024.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 1:16 pm